Recall Initiated Voluntarily by A.P. Deauville
The Food and Drug Administration (FDA) has announced the recall of nearly 70,000 cases of deodorant products distributed across the United States due to potential manufacturing concerns. The recall was voluntarily initiated by A.P. Deauville, LLC, a Pennsylvania-based company, approximately one week ago. The recall has not yet received a formal classification indicating its level of health risk.
The affected deodorants are all part of the “Power Stick” product line and include multiple scent variations. The FDA cited “cGMP deviations” as the cause, which refers to departures from the FDA’s Current Good Manufacturing Practices. These deviations can occur at any stage in the manufacturing process, but no further specifics were disclosed in the agency’s announcement.
Details of Recalled Products
Three product variants were included in the recall, with lot numbers and distribution quantities provided by the FDA:
- Power Stick for Her Roll-On Antiperspirant Deodorant Powder Fresh
Size: 1.8 oz (53 mL)
UPC: 815195019313
NDC #: 42913-038-00
Affected Lots: 032026B011, 032226B031, 051626C241, 061526C882, 071226D371, 071226D381, 082526E341, 082826E402
Cases Recalled: 21,265 - Power Stick Invisible Protection Roll-On Antiperspirant Deodorant Spring Fresh
Size: 1.8 oz (53 mL)
UPC: 815195018194
NDC #: 42913-039-00
Affected Lots: 031726A991, 041226B561, 062026C901, 062026C911, 071026D351, 071026D361, 071326D391, 111626G231
Cases Recalled: 22,482 - Power Stick Original Nourishing Invisible Protection Roll-On Antiperspirant Deodorant
Size: 1.8 oz (53 mL)
UPC: 815195018224
NDC #: 42913-040-00
Affected Lots: 101225D781, 032926B281, 032826B221, 041126B531, 062226D011, 070626D301, 070626D333, 111026G051, 111326G091, 111626G221
Cases Recalled: 23,467
No Reported Injuries or Health Issues
So far, the FDA has not received reports of adverse health effects linked to the recalled products. However, the agency urges consumers who have purchased items matching the specified details to stop using them immediately and to follow recall instructions provided by the manufacturer.
The recall is still under evaluation, and consumers are encouraged to monitor the FDA website for any updates regarding classification or additional guidance.